CGNX vs BMI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

CGNX

54.4
AI Score
VS
CGNX Wins

BMI

50.1
AI Score

Investment Advisor Scores

CGNX

54score
Recommendation
HOLD

BMI

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CGNX BMI Winner
Revenue 424.60M 559.70M CGNX
Net Income 57.05M 124.46M CGNX
Gross Margin 41.2% 70.9% CGNX
Net Margin 13.4% 22.2% CGNX
Operating Income 74.55M 145.39M CGNX
ROE 8.4% 7.6% BMI
ROA 5.7% 5.7% CGNX
Total Assets 998.17M 2.18B CGNX
Cash 95.73M 302.52M CGNX
Current Ratio 2.42 3.93 CGNX
Free Cash Flow 51.34M 109.96M CGNX

Relative Price Performance (Last 90 Days)

CGNX 1M: +5.9% · 3M: +3.4% BMI 1M: -7.2% · 3M: -4.1%

Current Technical Phase

CGNX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.4 · Price: $64.22

BMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 38

RSI (14): 37.8 · Price: $125.13

Fundamentals Snapshot

Metric CGNX BMI
Market Cap
Forward P/E 31.7 25.1
Trailing P/E 59.3 29.9
Revenue (TTM)
Revenue Growth 0.2% -0.1%
Gross Margin 0.7% 0.4%
Operating Margin 0.3% 0.2%
EPS 1.04 4.18
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CGNX is currently the stronger investment candidate, winning 10 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.